Regulation of human β-glucuronidase by A23187 and thapsigargin in the hepatoma cell line HepG2

Molecular Pharmacology

Volumn 59, Issue 2, 2001, Pages 177-182

  Sperker, Bernhard ^a   Tomkiewicz, Céline ^b   Burk, Oliver ^c   Barouki, Robert ^b   Kroemer, Heyo K ^a  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b INSERM   (France)

^c DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; CALCIMYCIN; THAPSIGARGIN;

ANIMAL CELL; ANTIBODY DIRECTED ENZYME PRODRUG THERAPY; ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN HEPG2; DRUG EFFECT; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME REGULATION; HEPATOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN RNA BINDING; RECEPTOR DOWN REGULATION; TRANSCRIPTION REGULATION;

EID: 0035139157     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.59.2.177     Document Type: Article

References (40)

1. Calcium-mediated inhibition of glucuronide production by epinephrine in the perfused rat liver
2. A novel one-step tumor-selective prodrug activation system
3. Tumor-selective prodrug activation by fusion protein-mediated catalysis
4. Elucidation of the mechanism enabling tumor selective prodrug monotherapy
5. Lysosomes, lysosomal enzymes, and cancer
6. Changes in translational yield regulate tissue-specific expression of β-glucuronidase
7. Coordinated induction of two unrelated glucose-regulated protein genes by a calcium ionophore: Human BiP/GRP78 and GAPDH
8. Androgen environment and βglucuronidase activity in the human kidney
9. Insulin downregulates cytechrome P450 2B and 2E expression at the post-transcriptional level in the rat hepatoma cell line
10. Fenofibrate modifies transaminase gene expression via a peroxlsome proliferator activated receptor α-dependent pathway
11. β-Glucuronidase and the action of steroid hormones
12. The presence of high β-glucuronidase activity in cancer tissue
13. Biochemical properties of recombinant human β-glucuronidase synthesized in baby hamster kidney cells
14. Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP
15. Construction and characterization of a fusion protein of single-chain anti-CD20 antibody and human β-glucuronidase for antibody-directed enzyme prodrug therapy
16. Immunoblotting protocols
17. 2+ ionophore A23187-stimulated secretion of azurophil granules in human polymorphonuclear leukocytes is largely mediated by endogenously formed leukotriene B4
18. Characterization of novel anthracycline prodrugs activated by human β-glucuronidase for use in antibody-directed enzyme prodrug therapy
19. Mis-sorting of procathepsin D in metastogenic tumor cells is not due to impaired synthesis of the phosphomannosyl signal
20. C-terminal processing of human β-glucuronidase. The propeptide is required for full expression of catalytic activity, intracellular retention, and proper phosphorylation
21. Structure of human β-glucuronidase reveals candidate lysosomal targeting and active-site motifs
22. Synthesis of self-immolative glucuronide-based prodrugs of phenol mustard
23. Regulation of transcription factor AP-2 by the morphogen retinoic acid and by second messengers
24. Cloning and characterization of the human β-glucuronidase gene
25. Enhanced uptake of doxorubicin into bronchial carcinoma: β-glucuronidase mediates release of doxorubicin from a glucuronide prodrug (HMR1826) at the tumor site
26. Cloning, sequencing, and expression of cDNA for human β-giucuronidase
27. Mammalian β-glucuronidase: Genetics, molecular biology and cell biology
28. A new spacer group derived from arylmalonaldehydes for glucuronylated prodrugs
29. Increase in cytosolic calcium upregulates the synthesis of type 1 plasminogen activator inhibitor in the human histiocytic cell line U937
30. - stimulate the accumulation of GRP78 mRNA in a cycloheximide dependent manner, whilst induction by hypoxia is independent of protein synthesis
31. 2+/calmodulin-dependent and -independent down-regulation of c-myb mRNA levels in erythropoietin-respensive murine erythroleukemia cells
32. Analysis of the 5′ flanking region of the human β-glucuronidase gene
33. β-Glucuronidase deficiency: Report of clinical, radiologic and biochemical features of a new mucopolysaccharidosis
34. Measurement of protein using bicinchoninic acid
35. The role of β-glucuronidase in drug disposition and drug targeting in humans
36. Interindividual variability in expression and activity of human β-glucuronidase in liver and kidney: Consequences for drug metabolism
37. High-performance liquid chromatographic quantification of 4-methylumbolliferyl-β-D-glucuronide as a probe for human β-glucuronldase activity in tissue homogenates
38. Characterization of the subunits and sugar moiety of human placental and leukemic β-glucuronidase
39. Androgen responsiveness of mouse kidney β-glucuronidase requires 5′-flanking and intragenic Gus-s sequences
40. Intermolecular association of lysosomal protein precursors during biosynthesis